We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Markets Mostly Higher but Sagging; Late Earnings Surge
Read MoreHide Full Article
We saw closes in the green almost completely across the board, with the sole miss being the Nasdaq, which came in -0.01% on the day (so close!). Otherwise, we got +0.41% gains on the Dow for the day, +0.11% for the S&P 500 and +1.06% on the Russell 2000 — the second-straight day the small-cap index was far ahead of the other major indexes. Indexes sagged for most of the day following a strong open.
After the bell rang in normal trading this morning, Pending Home Sales posted a big disappointment: -4.4%. This was way down from the +1.0% expected and the +1.7% reported in March, which had been indicating a big rebound in Pending Home Sales. All regions except the Midwest saw drops, while contract signings grew 51.7% for the month. Surging housing prices are clearly giving buyers cold feet; drastically rising input costs have flipped on inflation in the market, causing flagging sales.
A busy afternoon for earnings reports leads with salesforce.com’s (CRM - Free Report) Q1, which easily surpassed expectations on both top and bottom lines: $1.21 per share beat the 88 cents expected and the 70 cents per share reported in the year-ago quarter. Revenues of $5.96 billion took out the $5.88 billion estimate in the Zacks consensus. Fiscal year revenue guidance was ratcheted up, as well, to $26 billion. Our analysts had been expecting $25.7 billion.
The conference call will likely have a few questions regarding salesforce’s acquisition of Slack for $27.7 billion back in December. Integration looks to be key for the company’s growth trajectories to remain intact. In the company’s earnings statement, it continues to expect $50 billion revenue growth by full-year 2026, and the Slack business will likely be a big factor in this.
Costco (COST - Free Report) also topped expectations on both sales and earnings in its fiscal Q3: earnings of $2.75 per share outpaced the $2.28 estimate and $1.89 per share reported in the prior-year’s Q3, on $45.28 billion, slightly beyond the $45.20 billion analysts were looking for. Comps came in at 20.6%, with the U.S. growing 18%. Its e-Commerce business has grown 41% year over year. Shares are down slightly on the news, however; COST has gained 25% over the past year.
Beauty products major Ulta (ULTA - Free Report) more than doubled expectations on its bottom line in its Q1 earnings report this afternoon: $4.07 per share versus a $1.92 estimate. With masks coming off here toward the end of the pandemic, we see how companies like Ulta are already benefiting: last year’s quarterly EPS came in at -$1.12 per share (comps were an eye-popping 65.9%). Sales in the quarter reached $1.94 billion, easily bettering the $1.67 billion expected.
The Gap (GPS - Free Report) also stomped expectations for its Q1 results today, posting +48 cents per share versus -2 cents expected and -$2.51 per share in the year-ago quarter, Just like Ulta, the interest in re-socializing post-pandemic has brought big fortune to the American classic apparel firm compared to a year ago. Revenues came to $3.99 billion in the quarter, well ahead of the $3.54 billion. Current-year EPS has been ratcheted way up to a range of $1.60-1.75 per share, way ahead of the Zacks consensus $1.39.
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Image: Bigstock
Markets Mostly Higher but Sagging; Late Earnings Surge
We saw closes in the green almost completely across the board, with the sole miss being the Nasdaq, which came in -0.01% on the day (so close!). Otherwise, we got +0.41% gains on the Dow for the day, +0.11% for the S&P 500 and +1.06% on the Russell 2000 — the second-straight day the small-cap index was far ahead of the other major indexes. Indexes sagged for most of the day following a strong open.
After the bell rang in normal trading this morning, Pending Home Sales posted a big disappointment: -4.4%. This was way down from the +1.0% expected and the +1.7% reported in March, which had been indicating a big rebound in Pending Home Sales. All regions except the Midwest saw drops, while contract signings grew 51.7% for the month. Surging housing prices are clearly giving buyers cold feet; drastically rising input costs have flipped on inflation in the market, causing flagging sales.
A busy afternoon for earnings reports leads with salesforce.com’s (CRM - Free Report) Q1, which easily surpassed expectations on both top and bottom lines: $1.21 per share beat the 88 cents expected and the 70 cents per share reported in the year-ago quarter. Revenues of $5.96 billion took out the $5.88 billion estimate in the Zacks consensus. Fiscal year revenue guidance was ratcheted up, as well, to $26 billion. Our analysts had been expecting $25.7 billion.
The conference call will likely have a few questions regarding salesforce’s acquisition of Slack for $27.7 billion back in December. Integration looks to be key for the company’s growth trajectories to remain intact. In the company’s earnings statement, it continues to expect $50 billion revenue growth by full-year 2026, and the Slack business will likely be a big factor in this.
Costco (COST - Free Report) also topped expectations on both sales and earnings in its fiscal Q3: earnings of $2.75 per share outpaced the $2.28 estimate and $1.89 per share reported in the prior-year’s Q3, on $45.28 billion, slightly beyond the $45.20 billion analysts were looking for. Comps came in at 20.6%, with the U.S. growing 18%. Its e-Commerce business has grown 41% year over year. Shares are down slightly on the news, however; COST has gained 25% over the past year.
Beauty products major Ulta (ULTA - Free Report) more than doubled expectations on its bottom line in its Q1 earnings report this afternoon: $4.07 per share versus a $1.92 estimate. With masks coming off here toward the end of the pandemic, we see how companies like Ulta are already benefiting: last year’s quarterly EPS came in at -$1.12 per share (comps were an eye-popping 65.9%). Sales in the quarter reached $1.94 billion, easily bettering the $1.67 billion expected.
The Gap (GPS - Free Report) also stomped expectations for its Q1 results today, posting +48 cents per share versus -2 cents expected and -$2.51 per share in the year-ago quarter, Just like Ulta, the interest in re-socializing post-pandemic has brought big fortune to the American classic apparel firm compared to a year ago. Revenues came to $3.99 billion in the quarter, well ahead of the $3.54 billion. Current-year EPS has been ratcheted way up to a range of $1.60-1.75 per share, way ahead of the Zacks consensus $1.39.
Questions or comments about this article and/or its author? Click here>>
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Download Marijuana Moneymakers FREE >>